Navigation Links
VirtualHealth Technologies, Inc. Appoints Former DEA Assistant Administrator to its Advisory Board
Date:12/17/2008

LEXINGTON, Ky., Dec. 17 /PRNewswire-FirstCall/ -- VirtualHealth Technologies, Inc. (OTC Bulletin Board: VHGI) the owners of Veriscrip(TM), the nation's only proven Real-Time Prescription Monitoring System, announced today that it has appointed Anthony Bocchichio to its Advisory Board.

Mr. Bocchichio has over 37 years of experience in Federal drug law enforcement, 25 of which was spent with the Drug Enforcement Agency. He served as both Assistant Special Agent in Charge and Special Agent in Charge in Miami, FL and St. Louis, MO prior to taking the office of Assistant Administrator of the Operational Support Division of the DEA. Throughout his diverse career, Mr. Bocchichio has been responsible for the development and acquisition of new technology in order to better support the operational needs of the DEA. "I am very excited to be a part of such an innovative group of healthcare and technology professionals that make up the VirtualHealth team," says Mr. Bocchichio. "I look forward to sharing my insight into the challenges that face law enforcement in its fight to eliminate drug abuse and diversion."

Jim Renfro, VirtualHealth's President, was quoted as saying, "Anthony is just the right person we need to help provide guidance to our organization as we continue the enhancements to Veriscrip(TM) and in the continuing development of our security applications in Envoii Healthcare." VirtualHealth established its advisory board in an effort to bring in professionals from the various industries it serves that will assist in the successful execution of VirtualHealth's business goals.

This press release contains forward-looking statements that reflect the Company's current expectations regarding future events. While these statements reflect the Company's best current judgment, they are subject to risks and uncertainties. Actual results may differ significantly from projected results due to a number of factors,
'/>"/>

SOURCE VirtualHealth Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. VirtualHealth Technologies, Inc. Announces Management Appointment
2. VirtualHealth Technologies, Inc., Announces Its Associate, Private Access, Appoints Marc Kirshbaum as President & COO
3. VirtualHealth Technologies, Inc., Announces That Its Associate, Private Access, Will Be Partnering with Genetic Alliance To Accelerate Medical Research While Protecting Privacy
4. VirtualHealth Technologies CEO Scott Hare Discusses New Security and Encryption Technologies for Healthcare Sector with CEORoadshow.com in Exclusive Online Audio Interview
5. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
6. ReBuilder Medical Technologies, Inc. Signs Agreement for Distribution in Maine
7. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
8. Neurobiological Technologies, Inc. Announces Receipt of Determination Letter from NASDAQ
9. ReBuilder Medical Technologies, Inc. Increases Staffing by 30% in Three Weeks Due to Increase in Demand for All ReBuilder Medical Products
10. ReBuilder Medical Technologies, Inc. Reports Monthly Sales in 2007 Nearly Doubling Monthly Sales in 2006, Including Record Daily Sales in September 2007
11. ReBuilder Medical Technologies, Inc. Contracts with ETS to Manufacture the Newest Version of its ReBuilder Neuropathy Treatment Device; Expects Sales to Increase 30%

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... The Gymboree Corporation...O/COO, will present at the NASDAQ OMX 23rd Investo...l in London, England, on Wednesday, December 2, 20...roadcast of The Gymboree Corporation,s presentatio....com, click on "Our Company" at the bottom of the ...
(Date:11/27/2009)... Holdings has announced that it has become a natio...e largest nonprofit organizations dedicated to art... Delray Beach, FL (Vocus) Nov...XCHO), a company specializing in the marketing and...ts, has announced today that is has become a natio...
(Date:11/27/2009)...ealth™ announced today that Spectrum Health ...d Enterprise orthopedic templating solution and it... (PRWEB) November 27, 2009 -- Voyant...h (Grand Rapids, Michigan) has licensed its Trauma...its TraumaCad Extend workflow solution, to allow i...
(Date:11/26/2009)...ewswire/ -- With cold and flu season upon us, it,s... to control the spread of infections and avoid ill...eep ourselves healthy, but to avoid transmitting i..., CIC (certified in infection-control), nursing di...th at Hospital for Special Surgery (HSS) in Manhat...
(Date:11/26/2009)...y can lead to strains or worse , , THURS...ing wrong with stuffing your turkey full to bursti...th your suitcase as you pack for holiday trips. ,... U.S. hospital emergency rooms, doctors, offices, ...elated injuries, such as muscle strains, pulls and...
Breaking Medicine News(10 mins):Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4Health News:Pack Right for the Holidays to Avoid the ER 2
...e heart failure is the most frequent cause of hosp...ult to diagnose.// Treatment delays increase the c...sts of care. Already, doctors in many emergency...ch the heart stops pumping effectively. The su...
...lure is a chronic but deadly condition caused by t...ually enlarges as it becomes weaker and weaker. ...n, which will kill half of them within five years....ients who took statins ( work by reducing inflamma...
...rch shows older women with depression may have an ...archers in New York studied more than 93,600 older...iative Observational Study (WHI-OS). The WHI-OS is...ealth conditions. For this study, participants wer...
...d, skin cancers cause 16,000 deaths each year due ... body. // Previously, the best way to predict whe...g its thickness. It was believed the thicker a tum... found a new way to predict whether skin cancers w...
... to a recent study by Taiwanese experts , people b...getting virtually none. St John's Wort, or Hype...ugh doctors warn it can interfere with the effects... to be responsible for the psychoactive effects of...
...sia usually occurs without warning when a woman de...nancy.// About 5 percent of pregnant women are aff...e protein in their urine. If the condition progres...ndition, only delivery of the baby can resolve the...
Other Medicine News:Health News:‘Protein’ Produced By Overstressed Heart Muscle a Strong Indicator Of Heart Disea 2Health News:Predicting The Risk Of Preeclampsia During Pregnancy 2
(Date:11/25/2009)...XTON,Pa.,Nov.25/PRNewswire/--BioTrendsResearchGrou...lara report,thefirstinamulti-phasesyndicatedmarke...iotech,sStelara,fromproductlaunchthroughthefirstsi...uantitativeinformationfrom75uniqueDermatologistsan...ssesstrialanduseofStelara,obstaclestouse,typicalpa...
(Date:11/25/2009)..., COLLEGE PARK, Md., Nov. 25 /PRNewswire-USNews...eloping a shaving cream-like foam that stops sever...t Promising Security Idea category of the Global S... today. ,, Selected from more than 100 entries ...ir invention at the GSC Security Summit conference...
(Date:11/25/2009)... , HARBIN, China, Nov. 25 /PRNewswire-Asi...a Sky One Medical" or "the Company") (Nasdaq: CSK...pany developing and producing,over-the-counter dru...y,announced that the Company recently passed the C...aceutical and Biological Products ("ICPBP") examin...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Strong link found between concussions and brain tissue injury 55150 1Strong link found between concussions and brain tissue injury 55150 2Strong link found between concussions and brain tissue injury 55150 3Searching for an interglacial on Greenland 9684 1Searching for an interglacial on Greenland 9684 2Diplomat Specialty Pharmacy Partners With CareSource Launches Chronic Kidney Disease Management Program with Ohio Plan 55146 1Diplomat Specialty Pharmacy Partners With CareSource Launches Chronic Kidney Disease Management Program with Ohio Plan 55146 2
...Lower Incidence of Severe Cardiac Toxicity With Eq...s Reported, ATLANTA, Dec. 11 Cell Therapeutics, ... that preliminary data from,its phase II/III rando...t-line treatment of patients with aggressive non-H...ed pixantrone experienced less severe,(grade 3/4) ...
...tion aimed at enabling vaccine production facility...tional egg-based facility., * Once established, s...f, pandemic flu vaccine to commence within 12 wee...gland and ROCKVILLE, Md., Dec. 10, GE Healthcare, ...nd Novavax Inc. (Nasdaq: NVAX ), today announced ...
Other Medicine Technology:Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 2Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 3Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 4Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkin's Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting 5GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution 2GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution 3GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution 4
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
Medicine Products: